Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
2 | Acute myeloid leukemia 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
3 | Alcoholism 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
4 | Alcoholism 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
5 | Alzheimer disease 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
6 | Alzheimer disease 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
7 | Bladder cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
8 | Bladder cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
9 | Breast cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
10 | Breast cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
11 | cAMP signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
12 | cAMP signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
13 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
14 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
15 | Chemokine signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
16 | Chemokine signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
17 | Chronic myeloid leukemia 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
18 | Chronic myeloid leukemia 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
19 | Colorectal cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
20 | Colorectal cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
21 | Cushing syndrome 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
22 | Cushing syndrome 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
23 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
24 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
25 | Endocrine resistance 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
26 | Endocrine resistance 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
27 | Endometrial cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
28 | Endometrial cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
29 | ErbB signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
30 | ErbB signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
31 | Focal adhesion 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
32 | Focal adhesion 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
33 | FoxO signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
34 | FoxO signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
35 | Gastric cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
36 | Gastric cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
37 | Glioma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
38 | Glioma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
39 | Hepatitis B 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
40 | Hepatitis B 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
41 | Hepatitis C 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
42 | Hepatitis C 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
43 | Hepatocellular carcinoma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
44 | Hepatocellular carcinoma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
45 | Insulin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
46 | Insulin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
47 | Long-term depression 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
48 | Long-term depression 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
49 | Long-term potentiation 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
50 | Long-term potentiation 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
51 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
52 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
53 | Melanoma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
54 | Melanoma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
55 | mTOR signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
56 | mTOR signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
57 | Natural killer cell mediated cytotoxicity 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
58 | Natural killer cell mediated cytotoxicity 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
59 | Neurotrophin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
60 | Neurotrophin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
61 | Non-small cell lung cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
62 | Non-small cell lung cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
63 | Pancreatic cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
64 | Pancreatic cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
65 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
66 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
67 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
68 | Pathways in cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
69 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
70 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
71 | Progesterone-mediated oocyte maturation 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
72 | Progesterone-mediated oocyte maturation 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
73 | Prostate cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
74 | Prostate cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
75 | Proteoglycans in cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
76 | Proteoglycans in cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
77 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
78 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
79 | Regulation of actin cytoskeleton 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
80 | Regulation of actin cytoskeleton 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
81 | Renal cell carcinoma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
82 | Renal cell carcinoma 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
83 | Serotonergic synapse 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
84 | Serotonergic synapse 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
85 | Thyroid cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
86 | Thyroid cancer 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
87 | Vascular smooth muscle contraction 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Dabrafenib Dabrafenib 💬
| Dabrafenib | 034 [1] 34 💬
|
88 | Vascular smooth muscle contraction 💬 1 gene, 2 drugs (DrugBank) and 2 diseases |
BRAF [1] BRAF 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|